BNET Industries
Market Cap:$43.1B
Last Fiscal Year Sales:$34.1M
- Public
- UK
Dow Jones Description
Corvus was established to identify assets or companies which are either underperforming against established investment criteria or are undervalued in their current form but can be otherwise acquired or tactically repositioned in order to realise potential value. The Corvus management team has the backing of a number international funding partners. Our considered approach over the last decade has created over $600 million of value for investors across a number of investments, either directly or via special purpose investment vehicles.
CEO
Andrew ReganNumber of Employees 18
Peer Companies
NAICS Code Pharmacies and Drug Stores: 446110
News & Analysis
Filter by
cvs corp. and walgreen co. - All News and Analysis
Walgreens Lending: A Victim of Its Own Success
Walgreens WAG recently announced that it will be gradually slowing organic growth of new stores from a planned 5% down to 2.5%-3% starting next year and continuing through 2011. But Walgreens is a big chain, and even considering the slowdown there should be 30 to 50 new Walgreens outlets popping...
An Options Prescription for Walgreens and CVS Caremark
Paul Price submits: Walgreen Co. WAG and CVS Caremark Corp. CVS are the top two drugstore operators in America with estimated 2009 sales of about $64 billion and $97 billion respectively. Both fill prescriptions on-site as well as through their mail order facilities. Pharmacy revenues were about 65% and...
In Recession CVS Seems Better Positioned Than Walgreen
Geezeo.com submits: Retailers CVS Caremark Corporation (NYSE: CVS) and Walgreen Co. (NYSE: WAG) both experienced lower sales in January compared with December numbers. January saw the average monthly spending among Geezeo users fall 18% at Walgreen stores, compared to only a 4.92% decrease at...
CVS Caremark Cites Numerous Inaccuracies in Antitrust Memo Submitted to Longs Board
WOONSOCKET, R.I. -- CVS Caremark Corporation (NYSE:CVS) today took strong exception with a memorandum recently submitted to the Board of Directors of Longs Drug Stores Corporation (NYSE:LDG) by a law firm retained by CtW Investment Group, as follows: We are aware that the Board of Directors of Longs recently...
CVS Caremark Comments on FTC Investigation into Anti-Trust Aspects of Walgreens Proposal to Acquire Longs
WOONSOCKET, R.I. -- In response to the press release issued earlier today by Longs Drug Stores Corporation (NYSE:LDG) regarding the investigation by the Federal Trade Commission into the antitrust implications of a possible acquisition of Longs by Walgreens, CVS Caremark Corporation (NYSE:CVS) issued the following statement: "The opening of...
Walgreens vs. CVS: A Drug Store War Looms for Longs
CVS Caremark thought it had Longs Drug Stores in the bag after announcing a $2.61 billion merger agreement Aug. 12. But Longs' two biggest institutional owners pushed for a better offer, and on Friday they got one: Walgreens offered $3 billion for the West Coast chain. by Lisa Everitt
Health Benefit Providers - Industry Snapshot
Mike Havrilla submits:Health Benefit Providers: 33-Company Index Stats Health Benefit Providers: Top 5 Companies by Market CapHealth Benefit Providers: Top 5 Companies by Revenue The accompanying tables provide a snapshot of my 33-company Health Benefit Providers Index, which includes all types of pharmacy services (retail, mail order, institutional), pharmacy benefit managers,...
Essentials at every age: you can look your absolute best from decade to decade
When choosing skin care products, your age matters. Skin changes over time so the products that worked wonders when you were in your 20s may not be as effective as you get older. However, age is not the only reason to update your skin care essentials. Beauty brands are constantly...
Publicly held drug chains: their five-year track records
Publicly held drug chains: Their five-year track records Corporate sales (add 000) Chain ...
Low Payments by CVS Caremark Force Walgreens to Withdraw as a Provider from Four Insurance Plans
DEERFIELD, Ill. -- After many months of talks over unreasonably low and below-market payment rates by CVS Caremark Corp. for four prescription plans, Walgreens (NYSE:WAG)(NASDAQ:WAG) today withdrew as a pharmacy provider from the plans.
Decision Makers
| Name (plus bio) | Position |
|---|---|
| Andrew Regan | CEO |
| Julian Moore | Executive Director |
| Joanna Barrett | Executive |
| Michael Hirschfield | Executive |
Board of Directors
| Name (plus bio) | Position |
|---|---|
| Adrian Collins | Chairman |
| Edward Hanson | Board of Directors |
| Geoffrey Conway-Henderson | Board of Directors |
| Graham Porter | Board of Directors |
| Ian Tickler | Board of Directors |
| John Leat | Board of Directors |
| Richard Griffiths | Board of Directors |
| Simon Fry | Board of Directors |
Andrew Regan, aged 40, joined the Board as Chief Executive of Corvus Capital Inc in September 2004 and over the following year took the company to record profits of 22.1 million in 2005. Andrew sold his original business to Hobson plc in 1991 where he became Chief Executive of Hobson which was listed on the LSE. In 1994 Hobson plc acquired the Co-operative Wholesale Society's food and drinks manufacturing operations and the enlarged Hobson business was eventually sold to Hillsdown Holdings plc for 154 million by way of a recommended takeover in 1996. In 1997 Andrew led an attempt, which subsequently lapsed, to gain control of the CWS in a 1.2 billion take-over bid. Andrew is based in Geneva and he has no other directorships.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | CEO | Current |
| Corvus Capital Inc | Chief Executive | Current |
Julian is qualified as a chartered accountant with KPMG in Dublin. He has over seven years? experience in the finance industries in the UK, Ireland and South Africa. Julian is an executive director of Corvus Capital (SA) Holdings Limited, which is listed on the Johannesburg Stock Exchange, and is a consultant to CVS Management Limited and Corvus Capital Inc.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive Director | Current |
| Diamondtech Inc | Director | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive | Current |
| Diamondtech Inc | Board of Directors | Current |
| Corvus Capital Inc | Director | Current |
Michael qualified as a chartered accountant with Peat Marwick in 1988. He has held senior management positions with a number of public and private companies and has advised Corvus Capital Inc on its Company Secretary Administration since February 2003 and joined the Board as a non-executive director in January 2007.
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Executive | Current |
| Corvus Capital Inc | Board of Directors | Current |
| Peat Marwick International | Chartered Accountant | Former |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Chairman | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Organization | Position | Status |
|---|---|---|
| Corvus Capital Inc | Board of Directors | Current |
| Volume | 4,595,293 |
| Shares Outstanding | 1.4B |
| Market Cap | 43.1B |
| Year High | 38.27 |
| Year Low | 23.74 |
| Earnings Per Share | 2.46 |
| P/E Ratio | 12.4268 |
| Dividend | 0.305 |
| Yield | 0.997710 |
Industry Transcripts by Seeking Alpha
-
Cost Plus Inc. Q3 2009 Earnings Call Transcript
on Dec 03, 2009about CPWM
-
Collective Brands Inc. Q3 2009 Earnings Call Transcript
on Dec 02, 2009about PSS
-
Charming Shoppes, Inc. Q3 2009 Earnings Call Transcript
on Dec 02, 2009about CHRS
-
Conn's Inc. Q3 2009 Earnings Call Transcript
on Nov 25, 2009about CONN
-
Tiffany & Co. F3Q09 (Qtr End 10/31/09) Earnings Call Transcript
on Nov 25, 2009about TIF
IndustryTop Rated
- Walmart Readies Smaller Stores for Smarter Growth 2 votes
- Bed, Bath & Beyond Pursues Back to College Leadership Post Linens ' Things 1 votes
- Target Fashions a Comeback from Recession with Carlos Falchi, Jean Paul Gaultier 1 votes
- Kmart Rejuvenates Jaclyn Smith So Shoppers Forget Martha Stewart 1 votes
- Kohl's Greens Up Its Image, and the Timing Couldn't Be Better 1 votes


